Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

[Good practices for the surveillance and control of antimicrobial resistance].

Moro ML, Ciofi Degli Atti M, D'Amore C, Diegoli G, Forni S, Gagliotti C, Gemmi F, Iannazzo S, Miraglia V, Pan A, Pantosti A, Pitatlis S, Puro V, Ricchizzi E, Sarnelli B, Torti C, Zotti C.

Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193. doi: 10.19191/EP19.2-3.P185.058. Italian.

2.

Prevalence and incidence of surgical site infections in the European Union/European Economic Area: how do these measures relate?

Meijs AP, Prantner I, Kärki T, Ferreira JA, Kinross P, Presterl E, Märtin P, Lyytikäinen O, Hansen S, Szőnyi A, Ricchizzi E, Valinteliėnė R, Zerafa S, de Greeff SC, Berg TC, Fernandes PA, Štefkovičová M, Asensio A, Lamagni T, Sartaj M, Reilly J, Harrison W, Suetens C, Koek MBG.

J Hosp Infect. 2019 Jun 29. pii: S0195-6701(19)30276-2. doi: 10.1016/j.jhin.2019.06.015. [Epub ahead of print]

PMID:
31265856
3.

Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals.

Ciofi Degli Atti ML, D'Amore C, Gagliotti C, Zotti C, Ricchizzi E, Moro ML, Raponi M; Pediatric antibiotic resistance.

Ann Ig. 2019 Jan-Feb;31(1):3-12. doi: 10.7416/ai.2019.2253.

4.

Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017.

Ricchizzi E, Latour K, Kärki T, Buttazzi R, Jans B, Moro ML, Nakitanda OA, Plachouras D, Monnet DL, Suetens C, Kinross P; The Halt Study Group.

Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.2018.23.46.1800394.

5.

Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017.

Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, Jans B, Hopkins S, Hansen S, Lyytikäinen O, Reilly J, Deptula A, Zingg W, Plachouras D, Monnet DL; The Healthcare-Associated Infections Prevalence Study Group.

Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.2018.23.46.1800516. Erratum in: Euro Surveill. 2018 Nov;23(47):.

6.

Multidrug-resistant infections in long-term care facilities: extended-spectrum β-lactamase-producing Enterobacteriaceae and hypervirulent antibiotic resistant Clostridium difficile.

Giufrè M, Accogli M, Ricchizzi E, Barbanti F, Farina C, Fazii P, Mattei R, Sarti M, Barozzi A, Buttazzi R, Cosentino M, Nardone M, Savini V, Spigaglia P, Moro ML, Cerquetti M.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):275-281. doi: 10.1016/j.diagmicrobio.2018.02.018. Epub 2018 Feb 26.

PMID:
29571838
7.

Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study.

Giufrè M, Ricchizzi E, Accogli M, Barbanti F, Monaco M, Pimentel de Araujo F, Farina C, Fazii P, Mattei R, Sarti M, Barozzi A, Buttazzi R, Cosentino M, Nardone M, Savini V, Spigaglia P, Pantosti A, Moro ML, Cerquetti M.

Clin Microbiol Infect. 2017 Dec;23(12):961-967. doi: 10.1016/j.cmi.2017.04.006. Epub 2017 Apr 12.

8.

Reversion to virulence of a subtype B avian metapneumovirus vaccine: is it time for regulators to require availability of vaccine progenitors?

Cecchinato M, Catelli E, Lupini C, Ricchizzi E, Prosperi S, Naylor CJ.

Vaccine. 2014 Aug 6;32(36):4660-4. doi: 10.1016/j.vaccine.2014.06.030. Epub 2014 Jun 30.

PMID:
24992716
9.

Hospital statistics for antibiotics: defined versus prescribed daily dose.

Gagliotti C, Ricchizzi E, Buttazzi R, Tumietto F, Resi D, Moro ML.

Infection. 2014 Oct;42(5):869-73. doi: 10.1007/s15010-014-0649-6. Epub 2014 Jun 29.

PMID:
24973982
10.

Development and assessment of national performance indicators for infection prevention and control and antimicrobial stewardship in European long-term care facilities.

Cookson B, Mackenzie D, Kafatos G, Jans B, Latour K, Moro ML, Ricchizzi E, Van de Mortel M, Suetens C, Fabry J; National Network Representatives for the Healthcare-Associated Infections in Long-Term Care Facilities (HALT) Project.

J Hosp Infect. 2013 Sep;85(1):45-53. doi: 10.1016/j.jhin.2013.04.019. Epub 2013 Aug 6.

PMID:
23932737
11.

Infections and antimicrobial resistance in long term care facilities: a national prevalence study.

Moro ML, Ricchizzi E, Morsillo F, Marchi M, Puro V, Zotti CM, Prato R, Privitera G, Poli A, Mura I, Fedeli U.

Ann Ig. 2013 Mar-Apr;25(2):109-18. doi: 10.7416/ai.2013.1912.

PMID:
23471448
12.

Italian field survey reveals a high diffusion of avian metapneumovirus subtype B in layers and weaknesses in the vaccination strategy applied.

Cecchinato M, Lupini C, Ricchizzi E, Falchieri M, Meini A, Jones RC, Catelli E.

Avian Dis. 2012 Dec;56(4):720-4.

PMID:
23397844
13.

A turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine-derived avian metapneumovirus.

Lupini C, Cecchinato M, Ricchizzi E, Naylor CJ, Catelli E.

Avian Pathol. 2011 Oct;40(5):525-30. doi: 10.1080/03079457.2011.607428. Epub 2011 Aug 19.

PMID:
21854180
14.

A single polymerase (L) mutation in avian metapneumovirus increased virulence and partially maintained virus viability at an elevated temperature.

Brown PA, Lupini C, Catelli E, Clubbe J, Ricchizzi E, Naylor CJ.

J Gen Virol. 2011 Feb;92(Pt 2):346-54. doi: 10.1099/vir.0.026740-0. Epub 2010 Nov 3.

PMID:
21048037
15.

Avian metapneumovirus (AMPV) attachment protein involvement in probable virus evolution concurrent with mass live vaccine introduction.

Cecchinato M, Catelli E, Lupini C, Ricchizzi E, Clubbe J, Battilani M, Naylor CJ.

Vet Microbiol. 2010 Nov 20;146(1-2):24-34. doi: 10.1016/j.vetmic.2010.04.014. Epub 2010 Apr 20.

PMID:
20447777
16.

Field avian metapneumovirus evolution avoiding vaccine induced immunity.

Catelli E, Lupini C, Cecchinato M, Ricchizzi E, Brown P, Naylor CJ.

Vaccine. 2010 Jan 22;28(4):916-21. doi: 10.1016/j.vaccine.2009.10.149. Epub 2009 Nov 18.

PMID:
19931381
17.

Identification of two regions within the subtype A avian metapneumovirus fusion protein (amino acids 211-310 and 336-479) recognized by neutralizing antibodies.

Brown PA, Bonci M, Ricchizzi E, Jones RC, Naylor CJ.

Virus Res. 2009 Dec;146(1-2):13-8. doi: 10.1016/j.virusres.2009.08.009. Epub 2009 Aug 29.

PMID:
19720091

Supplemental Content

Loading ...
Support Center